Monthly prophylactic garadacimab significantly reduces hereditary angioedema attacks
1. Compared to placebo, monthly garadacimab significantly reduced the number of hereditary angioedema attacks per month. 2. Overall, garadacimab was ...
Tag: Garadacimab
Garadacimab significantly reduces frequency of hereditary angioedema exacerbations
1. Garadacimab significantly reduced the number of monthly attacks in patients with hereditary angioedema compared to placebo. 2. No serious ...